Bryostatin-1 has been shown to increase BDNF levels and improve cognitive ability in mouse studies performed in an AD model, showing promise that it may be effective for improving outcomes in APOE4 carriers after injury as well. The gene discussed is BDNF; the disease is Alzheimer disease.